Abstract:Abnormal regulation of Mg2+ in vascular smooth muscle cells (VSMC) has been implicated to play a role in vascular dysfunction in hypertension. This has been attributed, in part, to increased activation of the Na+/Mg2+ exchanger. We investigated whether inhibition of the Na+/Mg2+ exchanger by quinidine and imipramine influences development of hypertension in Ang II-infused rats. 16 week-old Sprague Dawley rats were randomly divided into 4 groups (6/group): Control (vehicle), Ang II (Ang II, 150 ng/kg/min by osmotic pump), Ang II+quinidine (5 mg/kg/day), Ang II+imipramine (5 mg/kg/day). Rats were treated for 4 weeks. Systolic blood pressure (SBP) and serum cations were measured weekly. Rats were killed by decapitation. Kidneys and mesenteric arteries were collected for determination of MAP kinase expression. [Mg2+]i and [Na+]i were measured in platelets by Mag-fura and SBFI methodology respectively. Phosphorylation of ERK1/2, p38 MAP kinase and JNK was assessed by Western blots using phosphospecific antibodies. SBP increased significantly in the Ang II group (111±1 to 208±6 mmHg). In the quinidine and imipramine groups, SBP increased but the magnitude of increase was significantly less than the Ang II group (quinidine 173±6 mm Hg, imipramine 159±2 mmHg). Serum Mg2+, Ca2+, Na+ and K+ levels were not influenced by treatment. [Mg2+]i was significantly increased and [Na+]i was significantly decreased in the treated groups compared with Ang II group (p<0.01). Phosphorylation of ERK1/2, p38 MAP kinase and JNK was increased 3-5 fold in arteries and kidneys from Ang II rats compared with controls. Quinidine and imipramine significantly reduced (p<0.05) expression of ERK and p38 MAP kinase. Phosphorylation of JNK was not influenced by treatment. Our data demonstrate that quinidine and imipramine attenuate the development of hypertension in Ang II-infused rats. This is associated with increased [Mg2+]i and decreased [Na+]i and reduced phosphorylation of vascular and renal ERK1/2 and p38 MAP kinase. These findings suggest that the Na+/Mg2+ exchanger plays a role in Ang II-dependent hypertension.

[Ca2+]i and PKC-α are involved in the inhibitory effects of Ib, a novel nonpeptide AngiotensinII subtype AT1 receptor antagonist, on AngiotensinII-induced vascular contraction in vitro

[Ca2+](I) And Pkc-Alpha Are Involved In The Inhibitory Effects Of 1b, A Novel Nonpeptide Angiotensinii Subtype At(1) Receptor Antagonist, On Angiotensinii-Induced Vascular Contraction In Vitro

Characterization of Angiotensin II Antagonism Displayed by Ib, a Novel Nonpeptide Angiotensin AT1 Receptor Antagonist

PKC-dependent Extracellular Signal-Regulated Kinase 1/2 Pathway is Involved in the Inhibition of Ib on AngiotensinII-induced Proliferation of Vascular Smooth Muscle Cells

Antihypertensive Effects of a New Angiotensin Type 1 Receptor Antagonist I B on Rats

Structural Insights into Angiotensin Receptor Signaling Modulation by Balanced and Biased Agonists.

Interleukin-10 Inhibits Angiotensin II-induced Decrease in Neuronal Potassium Current

Structural Basis for Ligand Recognition and Functional Selectivity at Angiotensin Receptor.

Abstract 5254: The Role of Caveolae on the Inhibition of Coronary Arterial BK Channels by Angiotensin II in Control and Diabetic Rats

Angtensin II elicits a cAMP-dependent intestinal anion secretion by stimulating PGE2 release through AT1 subtype receptors in rat ileum

Interplay of Angiotensin 1‐7 and Angiotensin II in the Regulation of Voltage‐gated Potassium Current in the Glomus Cells of Carotid Body

The angiotensin II AT1 receptor structure-activity correlations in the light of rhodopsin structure

Angiotensin II enhances hyperpolarization-activated currents in rat aortic baroreceptor neurons: involvement of superoxide.

The inhibitory effect of BKCa channels induced by autoantibodies against angiotensin II type 1 receptor is independent of AT1R

Angiotensin Iv Protects Against Angiotensin Ii-Induced Cardiac Injury Via At4 Receptor

Prostanoids contribute to regulation of inwardly rectifying K+ channels in intrarenal arterial smooth muscle cells

Exploiting the Cellular Actions of Skca and Ikca Channels to Manipulate Endothelial Function and Vascular Tone

Urotensin-II Receptor Stimulation of Cardiac L-type Ca2+ Channels Requires the βγ Subunits of Gi/o-protein and Phosphatidylinositol 3-Kinase-dependent Protein Kinase C β1 Isoform

Type 1 IP3 receptors activate BKCa channels via local molecular coupling in arterial smooth muscle cells

Inhibition of the Na+/Mg2+ exchanger decreases blood pressure and modulates vascular ERK1/2 and p38 MAP kinase phosphorylation in Ang II-induced hypertensive rats

Role of PKC in the novel synergistic action of urotensin II and angiotensin II and in urotensin II-induced vasoconstriction.